| 3 V Asset Management |
| 3i Group plc |
| 4- Antibody AG |
| 5AM Ventures |
| Abingworth Management Limited |
| ABN AMRO Bank |
| ABN AMRO Rothschild |
| Accelerex GmbH |
| ACE BioSciences A/S |
| Actelion |
| Adamant Biomedical Investments |
| Addex Pharmaceuticals Ltd. |
| ADVENTRX Pharmaceuticals Inc. |
| Adveq Management |
| Advisor |
| Aescap Venture |
| Affectis Pharmaceuticals AG |
| Affimed Therapeutics AG |
| Aisling Capital |
| AKALPA, Toder & Partner in LifeSciences |
| Alexea Consulting |
| Algeta ASA |
| Alltracel Pharmaceuticals plc. |
| Alta Partners |
| American Stock Exchange |
| AM-Pharma |
| Anián, a Reuters Business |
| Apeiron Biologics GmbH |
| Aravis Venture Associates AG |
| Archimedes Pharma Ltd. |
| Archivel Farma S.L. |
| AstraZeneca |
| Atila Ventures GmbH |
| Atlas Venture |
| AVONTEC GmbH |
| B.R.A.I.N. |
| BankInvest Biomedical Venture |
| Basilea Pharmaceutica AG |
| Bay City Capital LLC |
| Bayhill Therapeutics |
| BB Biotech Ventures |
| BBS Capital Partners |
| Bellevue Asset Management |
| Bio IB |
| Bio Tissue Technologies GmbH |
| BioConnect AG |
| biolitec AG |
| BioMedInvest AG |
| Bionomics Limited |
| Biota Holdings Ltd. |
| Biotie Therapies Corp. |
| BioTOP Berlin-Brandenburg |
| BioWorld Europe GmbH |
| BioXell |
| Borean Pharma ApS |
| BOSCH, GRAF von STOSCH, JEHLE |
| Brane Discovery |
| Breslin AG |
| Bryan, Garnier & Co |
| BSI SA |
| CapMan Life Science |
| CardioVascular BioTherapeutics Inc. |
| CBT Advisors |
| CDC Innovation |
| Cellerix S.L. |
| CellTraffix Inc. |
| Cellzome AG |
| CeNeS Pharmaceuticals plc. |
| Chroma Therapeutics Ltd. |
| Citigate Dewe Rogerson |
| Clinuvel |
| CMS-ConsulMed Services |
| Collins Stewart Tullett plc |
| Combinature AG |
| Consultant |
| Cosmo Pharmaceuticals S.p.A. |
| Covagen AG Tethis S.r.l. |
| Credit Suisse |
| Curis, Inc. |
| Cylene Pharmaceuticals, Inc. |
| DBV Technologies |
| De Facto Communications |
| De Mello LifeSciences Group Ltd |
| Deutsche Bank AG |
| Direvo Biotech AG |
| Dow Jones |
| Dunhaw Capital Partners LLP |
| DyoDelta Biosciences |
| DZ Bank |
| Earlybird Venture Capital |
| Economic Development Canton of Zurich |
| Edmond de Rothschild Investment Partners |
| EFG Private Bank AG |
| EMBL Ventures GmbH |
| Endeavour Vision SA |
| Epigenomics AG |
| Epiphany Biosciences, Inc. |
| Equity Development Ltd. |
| Ernst & Young |
| ESBATech AG |
| European Equity Partners |
| EVA - the Basel life sciences start-up agency |
| Evolva S.A. |
| Exane BNP Paribas |
| F. Hoffmann-La Roche |
| Faegre & Benson LLP |
| Faust Pharmaceuticals, SA |
| Ferghana Europe LLP |
| FHR Consult |
| Financial Dynamics |
| Finanz und Wirtschaft |
| Fongit Seed Invest SA |
| Forbion Capital Partners |
| Fortis Private Investment Management |
| f-star |
| GENEART GmbH |
| GiMV NV |
| GlaxoSmithKline |
| Global Life Science Ventures |
| Glycotope GmbH |
| GlycoVaxyn AG |
| GoingPublic Media AG |
| Grace Advisory |
| Grahaem Brown Consulting Limited |
| Greater Zurich Area |
| Handelszeitung |
| Harvard Medical School |
| HBM Partners AG |
| Helvea |
| Helvea SA |
| Hesperion Ltd. |
| High-Tech Gründerfonds Management |
| Hoffmann-La Roche Ltd. |
| immatics biotechnologies GmbH |
| Incentive Asset Management |
| Industrifonden |
| ING Bank Belgium |
| ING Wholesale Banking |
| Innovator Capital Limited |
| Intelligence Dynamics |
| Intercell AG |
| Intercytex |
| Investment New Zealand |
| ISA - Invest in Sweden Agency |
| Jado Technologies |
| Karus Therapeutics |
| Katan Associates |
| Kresta, Schnider & Partners |
| Kuros Biosurgery AG |
| Landsbanki Kepler |
| Le Temps |
| Lectus Therapeutics Ltd. |
| LGT Capital Partners |
| Life Science & Financing - BRESLIN |
| LifeCycle Pharma |
| Lilly |
| LipoNova AG |
| Lipoxen plc. |
| LoibertingerTrust |
| LSP |
| MacroImmune |
| Matignon Technologies |
| MC Services |
| Media Speak |
| Medtronic Europe |
| Merck & Co., Inc |
| Mergermarket |
| MerLion Pharmaceuticals |
| MHB |
| Micromet, Inc. |
| Mirabaud Asset Management |
| Molecular Partners AG |
| MolMed S.p.A |
| Morvus Technology |
| Mummert & Company |
| MVM Life Science Partners |
| Nabriva Therapeutics Forschungs GmbH |
| NatImmune A/S |
| Neomed |
| Newron Pharmaceuticals SpA |
| Nextech Venture |
| NGN Capital |
| Noble Fund Managers |
| Northbank Communications |
| NovaQuest |
| Novartis Pharma AG |
| Novartis Pharmaceuticals |
| Novartis Venture Fund |
| Novo A/S |
| NOXXON Pharma AG |
| NZB Neue Zurcher Bank |
| Oakes, Lyman & Co. Ltd. |
| Oakley Securities Ltd. |
| Objective Capital |
| OctoPlus N.V. |
| Optimata Ltd. |
| Oridion Systems Ltd. |
| Oxford Genome Sciences Ltd. |
| Pacific Edge Biotechnology Ltd. |
| Palau Pharma, S.A. |
| PanGenetics UK Ltd. |
| Paramount BioCapital |
| Paul Capital Partners |
| Pernet Portfolio Management |
| Pfizer, Inc. |
| Phenex Pharmaceuticals |
| Photocure ASA |
| Phytoceuticals Ltd. |
| Piper Jaffray Ltd |
| PolyMedix Inc. |
| PricewaterhouseCoopers |
| Quanta Fluid Solutions Ltd. |
| Quisisana AG |
| RBC Capital Markets |
| Reuters |
| Revotar Biopharmaceuticals AG |
| Rochat & Partners |
| Rosenow Grob Schilling |
| Rowiak GmbH |
| Sal. Oppenheim Jr. & Cie |
| Sal. Oppenheim Jr. & Cie. (Schweiz) AG |
| Samaritan Pharmaceuticals, Inc |
| Santhera Pharmaceuticals |
| Sectoral Asset Management |
| SEED |
| Seton Services |
| Seventure Partners |
| SG Securities |
| Shogoo Pharmaceuticals AG |
| SHS Gesellschaft für Beteiligungsmanagement mbH |
| Silence Therapeutics AG |
| Silence Therapeutics plc. |
| Sinclair Pharma plc. |
| Skintek |
| SKS Consulting |
| SkyePharma plc. |
| Sofinnova Partners |
| South East Growth Fund |
| Speedel |
| SR One |
| Stierli Investor Relations |
| Stocks |
| Stratos Bio |
| SuppreMol GmbH |
| Suterscience LLC |
| Swiss Biotech |
| Swiss Equity Magazine |
| SWX Swiss Exchange |
| Syngenta Biopharma |
| Synosia Therapeutics |
| Syntaxin Ltd |
| Tech Investor Ltd. |
| The Genetics Company |
| The Investor Relations Firm AG |
| Thiakis Limited |
| Thomson Scientific |
| Tiburon Bio Consulting GmbH |
| TiGenix |
| Tilocor International SA |
| Toucan Capital |
| Trout Group International LLC |
| Truffle Venture |
| TVM Capital |
| UBS AG |
| Union Investment Privatfonds GmbH |
| United Technologies AG |
| Venn Life Sciences |
| Ventech |
| Ventis Inc. |
| Venture Valuation AG |
| Versant Ventures |
| VI Partners AG |
| VISCHER |
| Warburg Pincus LLC |
| Wellington Partners |
| WestLB AG |
| Widmann Associates |
| Wilex AG |
| XBiotech Inc. |
| XOMA Ltd. |
| Yorkville Advisors, LLC |
| Ysios Capital Partners SGECR SA |
| Zurich University Hospital |